These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Tumor site discordance in mismatch repair deficiency in synchronous endometrial and ovarian cancers. Kim SR; Tone A; Kim R; Cesari M; Clarke B; Eiriksson L; Hart T; Aronson M; Holter S; Lytwyn A; Maganti M; Oldfield L; Gallinger S; Bernardini MQ; Oza AM; Djordjevic B; Lerner-Ellis J; Van de Laar E; Vicus D; Pugh TJ; Pollett A; Ferguson SE Int J Gynecol Cancer; 2020 Dec; 30(12):1951-1958. PubMed ID: 33082239 [TBL] [Abstract][Full Text] [Related]
4. Double somatic mismatch repair gene pathogenic variants as common as Lynch syndrome among endometrial cancer patients. Hampel H; Pearlman R; de la Chapelle A; Pritchard CC; Zhao W; Jones D; Yilmaz A; Chen W; Frankel WL; Suarez AA; Cosgrove C; Backes F; Copeland L; Fowler J; O'Malley D; Salani R; McElroy JP; Stanich PP; Goodfellow P; Cohn DE Gynecol Oncol; 2021 Jan; 160(1):161-168. PubMed ID: 33393477 [TBL] [Abstract][Full Text] [Related]
5. Association of Mismatch Repair Mutation With Age at Cancer Onset in Lynch Syndrome: Implications for Stratified Surveillance Strategies. Ryan NAJ; Morris J; Green K; Lalloo F; Woodward ER; Hill J; Crosbie EJ; Evans DG JAMA Oncol; 2017 Dec; 3(12):1702-1706. PubMed ID: 28772289 [TBL] [Abstract][Full Text] [Related]
6. Germline MLH1 Mutations Are Frequently Identified in Lynch Syndrome Patients With Colorectal and Endometrial Carcinoma Demonstrating Isolated Loss of PMS2 Immunohistochemical Expression. Dudley B; Brand RE; Thull D; Bahary N; Nikiforova MN; Pai RK Am J Surg Pathol; 2015 Aug; 39(8):1114-20. PubMed ID: 25871621 [TBL] [Abstract][Full Text] [Related]
7. Colon and endometrial cancers with mismatch repair deficiency can arise from somatic, rather than germline, mutations. Haraldsdottir S; Hampel H; Tomsic J; Frankel WL; Pearlman R; de la Chapelle A; Pritchard CC Gastroenterology; 2014 Dec; 147(6):1308-1316.e1. PubMed ID: 25194673 [TBL] [Abstract][Full Text] [Related]
8. Universal screening for Lynch syndrome in endometrial cancers: frequency of germline mutations and identification of patients with Lynch-like syndrome. Dillon JL; Gonzalez JL; DeMars L; Bloch KJ; Tafe LJ Hum Pathol; 2017 Dec; 70():121-128. PubMed ID: 29107668 [TBL] [Abstract][Full Text] [Related]
9. Initial screening by immunohistochemistry is effective in universal screening for Lynch syndrome in endometrial cancer patients: a prospective observational study. Tsuruta T; Todo Y; Yamada R; Kuwahara K; Kurosu H; Minowa K; Minoura Y; Minobe S; Suzuki H; Kato H Jpn J Clin Oncol; 2022 Jul; 52(7):752-758. PubMed ID: 35438162 [TBL] [Abstract][Full Text] [Related]
10. [Genetic analysis of 45 patients with suspected Lynch syndrome using next-generation sequencing]. Yao ZG; Cheng XK; Lin CH; Li J; Lyu BB; Li JM; Jing HY; Qin YJ; Sun XC Zhonghua Zhong Liu Za Zhi; 2021 Aug; 43(8):843-849. PubMed ID: 34407589 [No Abstract] [Full Text] [Related]
11. Universal endometrial cancer tumor typing: How much has immunohistochemistry, microsatellite instability, and MLH1 methylation improved the diagnosis of Lynch syndrome across the population? Kahn RM; Gordhandas S; Maddy BP; Baltich Nelson B; Askin G; Christos PJ; Caputo TA; Chapman-Davis E; Holcomb K; Frey MK Cancer; 2019 Sep; 125(18):3172-3183. PubMed ID: 31150123 [TBL] [Abstract][Full Text] [Related]
12. Utility of MLH1 methylation analysis in the clinical evaluation of Lynch Syndrome in women with endometrial cancer. Bruegl AS; Djordjevic B; Urbauer DL; Westin SN; Soliman PT; Lu KH; Luthra R; Broaddus RR Curr Pharm Des; 2014; 20(11):1655-63. PubMed ID: 23888949 [TBL] [Abstract][Full Text] [Related]
13. Frequent PIK3CA Mutations in Colorectal and Endometrial Tumors With 2 or More Somatic Mutations in Mismatch Repair Genes. Cohen SA; Turner EH; Beightol MB; Jacobson A; Gooley TA; Salipante SJ; Haraldsdottir S; Smith C; Scroggins S; Tait JF; Grady WM; Lin EH; Cohn DE; Goodfellow PJ; Arnold MW; de la Chapelle A; Pearlman R; Hampel H; Pritchard CC Gastroenterology; 2016 Sep; 151(3):440-447.e1. PubMed ID: 27302833 [TBL] [Abstract][Full Text] [Related]
14. Lynch syndrome-associated endometrial carcinoma with MLH1 germline mutation and MLH1 promoter hypermethylation: a case report and literature review. Yokoyama T; Takehara K; Sugimoto N; Kaneko K; Fujimoto E; Okazawa-Sakai M; Okame S; Shiroyama Y; Yokoyama T; Teramoto N; Ohsumi S; Saito S; Imai K; Sugano K BMC Cancer; 2018 May; 18(1):576. PubMed ID: 29783979 [TBL] [Abstract][Full Text] [Related]
15. Prevalence and molecular characteristics of DNA mismatch repair deficient endometrial cancer in a Japanese hospital-based population. Yamamoto A; Yamaguchi T; Suzuki O; Ito T; Chika N; Kamae N; Tamaru JI; Nagai T; Seki H; Arai T; Tachikawa T; Akagi K; Eguchi H; Okazaki Y; Ishida H Jpn J Clin Oncol; 2021 Jan; 51(1):60-69. PubMed ID: 32844218 [TBL] [Abstract][Full Text] [Related]
16. Testing strategies for Lynch syndrome in people with endometrial cancer: systematic reviews and economic evaluation. Stinton C; Jordan M; Fraser H; Auguste P; Court R; Al-Khudairy L; Madan J; Grammatopoulos D; Taylor-Phillips S Health Technol Assess; 2021 Jun; 25(42):1-216. PubMed ID: 34169821 [TBL] [Abstract][Full Text] [Related]
17. Consequences of universal MSI/IHC in screening ENDOMETRIAL cancer patients for Lynch syndrome. Batte BA; Bruegl AS; Daniels MS; Ring KL; Dempsey KM; Djordjevic B; Luthra R; Fellman BM; Lu KH; Broaddus RR Gynecol Oncol; 2014 Aug; 134(2):319-25. PubMed ID: 24933100 [TBL] [Abstract][Full Text] [Related]
18. Women with synchronous primary cancers of the endometrium and ovary: do they have Lynch syndrome? Soliman PT; Broaddus RR; Schmeler KM; Daniels MS; Gonzalez D; Slomovitz BM; Gershenson DM; Lu KH J Clin Oncol; 2005 Dec; 23(36):9344-50. PubMed ID: 16361634 [TBL] [Abstract][Full Text] [Related]
19. Somatic Sequencing and Microsatellite Instability Results From Mismatch Repair-deficient Endometrial Carcinoma Patients Without Lynch Syndrome ("Lynch-like" tumors): Implications for Heritable Cancer Screening, Molecular Prognostication, and Immunotherapeutic Vulnerability. Makia NL; Thomas M; Ring KL; Moskaluk CA; Mills AM Am J Surg Pathol; 2023 Aug; 47(8):878-888. PubMed ID: 37248962 [TBL] [Abstract][Full Text] [Related]
20. Combined Microsatellite Instability, MLH1 Methylation Analysis, and Immunohistochemistry for Lynch Syndrome Screening in Endometrial Cancers From GOG210: An NRG Oncology and Gynecologic Oncology Group Study. Goodfellow PJ; Billingsley CC; Lankes HA; Ali S; Cohn DE; Broaddus RJ; Ramirez N; Pritchard CC; Hampel H; Chassen AS; Simmons LV; Schmidt AP; Gao F; Brinton LA; Backes F; Landrum LM; Geller MA; DiSilvestro PA; Pearl ML; Lele SB; Powell MA; Zaino RJ; Mutch D J Clin Oncol; 2015 Dec; 33(36):4301-8. PubMed ID: 26552419 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]